See All Slides - tctmd.com

Slides

Presentation

STEM-AMI: cMRI and Other Observations at 3 Years

Presenter: Giulio Pompilio

January 23, 2013

Presentation Cell Therapy 2013

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Presenter: Wolfgang-Michael Franz

January 22, 2013

Presentation Cell Therapy 2013

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

Presenter: Stephen G. Ellis

January 22, 2013

Presentation Cell Therapy 2013

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

Presenter: Jonathan Sackner-Bernstein

January 22, 2013

Presentation Cell Therapy 2013

BMAC for CLI: Status of a Phase 3 Trial

Presenter: Amit Patel

January 22, 2013

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation

Same-Day Discharge Compared with Overnight Hospitalization After Uncomplicated PCI

Presenter: E. Abdelaal

January 22, 2013

Presentation Cell Therapy 2013

SDF-1 Plasmid for Treatment of Critical Limb Ischemia

Presenter: David Paul Slovut

January 22, 2013

Presentation Cell Therapy 2013

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Presenter: Frank J. Giordano

January 22, 2013

$Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study$

Presentation Cell Therapy 2013

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Presenter: Thomas J. Povsic

January 22, 2013

Advertisement

Slides

STEM-AMI: cMRI and Other Observations at 3 Years

Sitagliptin plus Granulocyte-Colony Stimulating Factor in Acute Myocardial Infarction

Regenerative Therapies After Acute Myocardial Infarction- Focus on Endpoints

AMR-001 Phase 1 Outcome and PreSERVE Study Design: Autologous CD34+ Cells

BMAC for CLI: Status of a Phase 3 Trial

CD-34+ Cells for Ischemic Heart Failure

Same-Day Discharge Compared with Overnight Hospitalization After Uncomplicated PCI

SDF-1 Plasmid for Treatment of Critical Limb Ischemia

A Phase 2 Pilot Study to Evaluate the Safety and Activity of BB3 as an Adjunct to PCI in Subjects Presenting with STEMI

Mobilized CD34+ Cells for Refractory Angina: Design and Update for the Phase 3 RENEW Study

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content